Literature DB >> 11561576

Antimicrobial susceptibility of Clostridium difficile by E test.

S H Cheng1, F Y Chu, S H Lo, J J Lu.   

Abstract

The in vitro inhibitory activity of 11 antimicrobials against 44 clinical isolates of Clostridium difficile was investigated. Minimum inhibitory concentrations (MICs) were determined using E test. Metronidazole (MIC90 0.38 microg/mL), teicoplanin (MIC90 0.75 microg/mL) and vancomycin (MIC90 1.0 microg/mL) were very active against the isolates examined, whereas, resistance to imipenem, cefoxitin, clindamycin and ciprofloxacin was found in most of the tested strains. We concluded that teicoplanin warrants clinical trials to determine its adequate dosage to treat C. difficile infection. The commonly used regimens to treat intra-abdominal and/or anaerobic infections (eg. imipenem, cefoxitin, clindamycin or ciprofloxacin) need special attention, while considering the side effects of C. difficile-associated diarrhea.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11561576

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  2 in total

1.  Investigation of toxin gene diversity and antimicrobial resistance of Clostridium difficile strains.

Authors:  Shanshan Zhu; Huaping Zhang; Xinsheng Zhang; Chao Wang; Guangming Fan; Weifeng Zhang; Gang Sun; Huihong Chen; Liming Zhang; Zhaoyun Li
Journal:  Biomed Rep       Date:  2014-07-08

2.  Antibiotic susceptibility of Clostridium difficile is similar worldwide over two decades despite widespread use of broad-spectrum antibiotics: an analysis done at the University Hospital of Zurich.

Authors:  Andrea C Büchler; Silvana K Rampini; Simon Stelling; Bruno Ledergerber; Silke Peter; Alexander Schweiger; Christian Ruef; Reinhard Zbinden; Roberto F Speck
Journal:  BMC Infect Dis       Date:  2014-11-26       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.